How can drug‑induced hepatitis be distinguished from viral hepatitis and alcoholic hepatitis?

Differentiating Drug-Induced, Viral, and Alcoholic Hepatitis

The differentiation relies on a systematic approach combining detailed exposure history, specific laboratory patterns, serological testing, and when needed, liver biopsy—with the key being that drug-induced hepatitis typically occurs within 6 months of drug initiation, alcoholic hepatitis shows AST/ALT ratio >2 with history of excessive alcohol use (>40g/day in men, >20g/day in women), and viral hepatitis is confirmed through specific serological markers.

Clinical History: The Foundation

Alcohol History:

• Document daily consumption: >40g/day (men) or >20g/day (women) suggests alcoholic liver disease 1
• Duration and pattern of drinking
• Recent binge episodes
• Consider objective testing: urinary ethyl-glucuronide/ethyl-sulphate, serum phosphatidylethanol 2

Drug/Medication History:

• Critical timing: Most idiosyncratic drug hepatotoxicity occurs within first 6 months of drug initiation 3
• A drug used continuously for >1-2 years is unlikely to cause de novo liver damage 3
• Document ALL medications including:
  • Prescription drugs (especially antibiotics, NSAIDs, statins, isoniazid)
  • Over-the-counter medications (particularly acetaminophen)
  • Herbal supplements and dietary products
  • Timing of last dose 2

Viral Exposure History:

• Recent travel to endemic areas (hepatitis E: Russia, Pakistan, Mexico, India) 3
• Risk factors for hepatitis B/C (injection drug use, sexual exposure, transfusions)
• Recent viral illness or vaccination 2

Laboratory Patterns: Key Discriminators

Alcoholic Hepatitis:

• AST/ALT ratio typically >2 (most distinctive feature) 1
• AST and ALT usually <300-400 U/L
• Anemia, leukocytosis, thrombocytopenia common 1
• Elevated bilirubin in severe cases
• May have elevated GGT

Drug-Induced Hepatitis:

• Can present as hepatocellular (ALT predominant), cholestatic (ALP predominant), or mixed pattern 2
• Hepatocellular pattern: ALT often markedly elevated (can be several thousand) 4
• Timing: onset typically within days to 6 months of drug exposure 3
• May have eosinophilia (suggests hypersensitivity) 5

Viral Hepatitis:

• ALT typically higher than AST (opposite of alcoholic hepatitis)
• ALT can be markedly elevated (>1000 U/L)
• Confirmed by specific serologies (see below)

Essential Serological Testing

Mandatory viral screening (even when another etiology suspected) 3:

First-line viral tests:

• Hepatitis A: IgM anti-HAV 2
• Hepatitis B: HBsAg, anti-HBc (IgG and IgM), HBV DNA 2
• Hepatitis C: anti-HCV, HCV RNA 2
• Hepatitis E: anti-HEV (IgG, IgM), HEV RNA (especially if recent travel or acute presentation) 3, 2
• HIV testing in at-risk patients 5

Second-line viral tests (in acute/icteric presentations):

• EBV, CMV, HSV, VZV serologies and PCR 2

Autoimmune markers (to exclude autoimmune hepatitis or drug-induced autoimmune-like hepatitis):

• ANA, ASMA, quantitative immunoglobulins (IgG, IgM, IgA) 2
• Anti-LKM1, anti-SLA if available 2
• Important: Elevated IgG >2× ULN and/or ASMA >1:80 suggests autoimmune hepatitis or overlap 6

Imaging Studies

Hepatobiliary ultrasound ± Doppler (all cases) 5:

• Exclude biliary obstruction
• Assess for portal/hepatic vein thrombosis
• Evaluate for hepatic metastases or masses
• Consider CT/MRI with contrast if ultrasound inadequate 2

Role of Liver Biopsy

Consider liver biopsy when:

1. Severe alcoholic hepatitis requiring corticosteroid therapy—biopsy provides definitive diagnosis and prognosis 1

2. Distinguishing drug-induced from autoimmune hepatitis:

   • Portal plasma cell-rich inflammation + absence of cholestasis → favors autoimmune hepatitis 5
   • Eosinophilic infiltration suggests drug-induced 5
   • Advanced fibrosis may favor autoimmune hepatitis over acute drug injury 5

3. Uncertain diagnosis despite comprehensive workup 2, 6

Diagnostic Algorithm

Step 1: Exclude biliary obstruction (ultrasound)

Step 2: Complete viral serologies (all cases, regardless of suspected etiology) 3

Step 3: Detailed exposure history:

• Alcohol quantification
• Drug timeline (focus on past 6 months)
• Travel history

Step 4: Assess laboratory pattern:

• AST/ALT ratio >2 + alcohol history → alcoholic hepatitis
• Recent drug exposure (<6 months) + negative viral serologies → drug-induced
• Positive viral serology → viral hepatitis

Step 5: Check autoimmune markers if:

• ALT >5× ULN (uncommon in isolated alcoholic or viral hepatitis) 6
• Hypergammaglobulinemia present
• Drug exposure present (to exclude drug-induced autoimmune-like hepatitis)

Step 6: Consider liver biopsy for:

• Severe alcoholic hepatitis (before steroids)
• Diagnostic uncertainty between drug-induced and autoimmune
• Atypical presentations

Critical Pitfalls to Avoid

1. Multiple etiologies can coexist: A patient with alcoholic liver disease can have concurrent viral hepatitis or drug injury 1

2. Drug-induced autoimmune-like hepatitis can mimic idiopathic autoimmune hepatitis with positive autoantibodies and elevated IgG 5, 6

3. Hepatitis C alone does not cause acute liver failure 3—if severe, look for other causes

4. Herpes simplex hepatitis may lack skin lesions in 50% of cases 3—consider in immunosuppressed or pregnant patients

5. Timing is crucial for drug causality: Drugs used for >1-2 years rarely cause new-onset hepatitis 3

6. Eosinophilia is not diagnostically useful for distinguishing drug-induced from autoimmune hepatitis 5

7. Viral serology may be falsely negative in patients with prior anti-CD20 treatment 2